HYDROXYTYROSOL ETHERS

Hydroxytyrosol ethers. The invention relates to hydroxytyrosol ethers derived from fatty alcohols and phenolic compounds of olive oil and the salts, solvates and hydrates thereof, which have an affinity for type 1 cannabinoid receptors (CB 1 ) and which can: prevent the oxidation of low-density lipo...

Full description

Saved in:
Bibliographic Details
Main Authors DE LA TORRE FORNELL, RAFAEL, CLAPES SABORIT, PEDRO, FITO COLOMER, MONTSERRAT, ALMEIDA COTRIM, BRUNO, ROMERO CUEVAS, MIGUEL, JOGLAR TAMARGO, JESUS, DECARA DEL OLMO, JUAN MANUEL, FARRE ALBALADEJO, MAGIN, COVAS PLANELLS, MARIA ISABEL, RODRIGUEZ DE FONSECA, FERNANDO
Format Patent
LanguageEnglish
Spanish
Published 13.07.2012
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Hydroxytyrosol ethers. The invention relates to hydroxytyrosol ethers derived from fatty alcohols and phenolic compounds of olive oil and the salts, solvates and hydrates thereof, which have an affinity for type 1 cannabinoid receptors (CB 1 ) and which can: prevent the oxidation of low-density lipoprotein (LDL) and modulate the actions regulated by said receptor, such as inducing satiety, controlling intake and reducing body fat. Éteres de hidroxitirosol derivados de alcoholes grasos y compuestos fenólicos del aceite de oliva y sus sales, solvatos e hidratos, que muestran afinidad por receptores cannabinoides tipo 1 (CB1) y son capaces de prevenir la oxidación de la Lipoproteína de Baja Densidad (LDL) y de modular las acciones reguladas por el citado receptor, tales como la inducción de la saciedad, el control de ingesta y la disminución de la grasa corporal.
Bibliography:Application Number: ES20100031878